Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine

BACKGROUND: Subarachnoid hemorrhage (SAH) is a devastating disease that affects over 30,000 Americans per year. Previous animal studies have explored the therapeutic effects of deferoxamine (DFX) via its iron-chelating properties after SAH, but none have assessed the necessity of microglial/macropha...

Descripción completa

Detalles Bibliográficos
Autores principales: LeBlanc, Robert H., Chen, Ruiya, Selim, Magdy H., Hanafy, Khalid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020472/
https://www.ncbi.nlm.nih.gov/pubmed/27618864
http://dx.doi.org/10.1186/s12974-016-0709-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020472/
https://www.ncbi.nlm.nih.gov/pubmed/27618864
http://dx.doi.org/10.1186/s12974-016-0709-1

Ejemplares similares